Direxion mRNA ETF (MSGR)
| Assets | $4.55M |
| Expense Ratio | 0.65% |
| PE Ratio | n/a |
| Shares Out | 280,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -10.78% |
| Volume | 3,040 |
| Open | 15.73 |
| Previous Close | 15.93 |
| Day's Range | 15.62 - 16.37 |
| 52-Week Low | 11.55 |
| 52-Week High | 19.55 |
| Beta | 2.11 |
| Holdings | 24 |
| Inception Date | Dec 9, 2021 |
About MSGR
The Direxion mRNA ETF (MSGR) is an exchange-traded fund that is based on the BITA Messenger RNA Technology index, a market-cap-weighted index of companies from the US, Canada, and Europe that contribute to the development and application of messenger RNA (mRNA) technology. MSGR was launched on Dec 9, 2021 and is managed by Direxion.
Top 10 Holdings
56.37% of assets| Name | Symbol | Weight |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | VRTX | 6.54% |
| BeiGene, Ltd. | BGNE | 6.50% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 6.39% |
| Moderna, Inc. | MRNA | 6.11% |
| BioNTech SE | BNTX | 6.01% |
| Arcturus Therapeutics Holdings Inc. | ARCT | 5.56% |
| Avidity Biosciences, Inc. | RNA | 4.94% |
| PTC Therapeutics, Inc. | PTCT | 4.86% |
| Maravai LifeSciences Holdings, Inc. | MRVI | 4.74% |
| Intellia Therapeutics, Inc. | NTLA | 4.72% |
News
Best-Performing ETFs of Last Week
Wall Street was downbeat last week. The S&P 500 (down 2.1%), the Dow Jones (down 1.7%), the Nasdaq Composite (down 2.7%) and the Russell 2000 (down 1.9%) -- all lost last week.
ETF Prime: Tom Hendrickson on Geopolitics & ETFs
On this week's episode of ETF Prime, host Nate Geraci is joined by Tom Hendrickson, president of ETF Trends and ETF Database, to discuss how recent geopolitical events are impacting the ETF world and ...
Leveraged ETF: How to Use & What's Hot Now?
Geared funds are complex products; here is what you should know.
Direxion Launches mRNA Technology-Focused ETF
Direxion has announced today in a press release the launch of their newest ETF that focuses on the applications and developments of messenger RNA technology, the Direxion mRNA ETF (MSGR). The fund loo...
Direxion Launches mRNA ETF (MSGR)
NEW YORK, Dec. 9, 2021 /PRNewswire/ -- Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR) . MSGR invests in companies believed to be at the forefront of the development and a...